Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA )

12.82 -0.36 (-2.73%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
Ginkgo Bioworks layoffs are coming for 400 of the company's employees as it seeks to reduce labor costs as part of a restructuring. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Ginkgo Bioworks Stock Is Sinking Today
There was double trouble for this beaten-down biotech stock. 
Via The Motley Fool
Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival
Via Benzinga
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Via Benzinga
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
It needs to work within the constraints imposed by these three issues. 
Via The Motley Fool
How Is The Market Feeling About Ginkgo Bioworks Holdings?
Via Benzinga
Is Ginkgo Bioworks Holdings Stock a Buy?
Can this struggling stock turn things around? 
Via The Motley Fool
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees. 
Via InvestorPlace
Exposures Product Safety
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains
Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff. 
Via InvestorPlace
7 Penny Stocks to Sell in June Before They Crash & Burn
It's way past time to dump these seven struggling penny stocks before things go from bad to worse for investors. 
Via InvestorPlace
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners. 
Via The Motley Fool
3 Sorry Biotech Stocks to Sell in May While You Still Can
Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell. 
Via InvestorPlace
Ginkgo Bioworks Stock: Bull vs. Bear
This innovative biotechnology company hopes to turn things around. 
Via The Motley Fool
Should You Buy the Dip on Ginkgo Bioworks Stock?
Its vision is ambitious, but can it actually be made to work? 
Via The Motley Fool
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
You don't need to buy her picks, but it's worth understanding them. 
Via The Motley Fool
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
Via Benzinga
Topics ETFs
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price. 
Via The Motley Fool
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Ginkgo Bioworks has become a penny stock -- and that's the least of its problems, 
Via The Motley Fool
Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs. 
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
4 Small-Cap Value Stocks That Could Go Parabolic
These four small-cap stocks scan as deeply undervalued right now. 
Via The Motley Fool
What's the Difference Between Biotech Stocks and TechBio Stocks?
A few enterprising businesses are marketing themselves differently. 
Via The Motley Fool
TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! 
Via InvestorPlace
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024
DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the... 
Via Benzinga
3 Meme Stocks to Sell in May Before They Crash & Burn
Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends. 
Via InvestorPlace
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.